"Change is part of life here – and that’s exciting. The nature and size of the business means we’re always looking for continuous improvement."

Charlotte Yates | Programme Director, Delivery Management Office

Inhalation is our focus. With more than 20 years’ experience, we help customers and partners succeed in bringing inhaled medicines to market. Customers choose us for our unique combination of inhalation development expertise, formulation science and device technology.

As an international community of scientists, engineers, regulatory specialists, quality managers and more, we working closely together to develop innovative, inhaled product development solutions that meet our customers’ needs and, ultimately, improve patients’ lives.

More about us Our services

Vectura at a glance


Annual reported
revenue in 2020


Patients using products
based on Vectura’s
Intellectual Property in 2020


Inhaled in-market
medicines, launched
by our partners
and licensees


People working
for Vectura

Our story

In just over 20 years, we’ve developed from a pharmaceutical start-up into an international company with world-leading inhalation capabilities. With global product development partnerships and an exciting ambition to be a market-leading CDMO, we’re set for continued growth.


Founded as a biotech company to commercialise respiratory pharmaceutical technologies originating from the University of Bath


Merges with a research group from the University that has been developing PowderHale® technology


Moves from University of Bath campus to Chippenham


Vectura Delivery Devices created in Cambridge


Floats on the London Stock Exchange Alternative Investment Market (AIM), raising £20.1m


Vectura Delivery Devices moves to the Cambridge Science Park


Buys Innovata Biomed, creating the UK's largest biotech company at the time


Becomes a FTSE Top 250 company


GlaxoSmithKline signs a collaboration agreement to use Vectura’s powder drug formulation


Launches Ultibro® Breezhaler® with Novartis in the EU and Japan


Acquires German pharmaceutical company Activaero for £108m


Our engineering teams move to a new site on the Cambridge Science Park


Merges with Skyepharma in a £440m deal


Generic GSK Ellipta® deal signed with Hikma – the largest product deal in the Group’s history 


Shifted focus to become leading inhalation CDMO, helping more customers to develop inhaled medicines

Our values

To enable us to help our customers bring their inhaled medicines to market we have a clear set of values that guide our decisions and actions.

Deliver for patients with pride
Create a great customer experience
Work together as one team
Do the right thing
Innovate and improve

We are agile, efficient and deliver our commitments. We take pride in successfully  developing medicines that transform lives.

Our customer focus guides everything we do. We use our insight and capability to create a great experience for our customers.

We collaborate to achieve shared goals, using our combined knowledge and expertise to enable success.

Quality is at the heart of everything we do. We work with integrity, consistently delivering to high standards.

We thrive on learning and apply our expertise to continually innovate and be the best at what we do.

Our future

Inhaled delivery is used to treat respiratory and non-respiratory diseases affecting millions of people around the world. At Vectura, we have the expertise and capability to help our customers and partners develop innovative inhaled products that can improve their lives.

That’s why we’re continuing to innovate, expanding our technical and scientific capabilities further. By recruiting adaptable, creative people who are committed to designing, developing and delivering ground-breaking solutions, we aim to delight customers and be a market-leading company in the inhalation CDMO space.

A responsible business


We are committed to playing our part in environmental stewardship by managing and reducing our environmental footprint. Our business already has a low impact on the environment, but we are taking steps to improve this further. Our priorities include reducing our carbon footprint, monitoring waste and improving supplier performance. In 2021, we have committed to aligning with and achieving certification to the ISO 14001:2015 Environmental Management standard.

Know more about our Environmental, Social and Governance (ESG) Strategy.


We believe operating ethically and having a long-term positive impact on society is a duty and a responsibility. The health and wellbeing of our people is paramount, and we support them to be engaged and inspired by their work. We also want to give back to the communities we are part of.

We continue to provide opportunities for colleagues to participate in local volunteering and fundraising via our Charitable Support Policy. Our highly effective and active Social Committee continues to organise a multitude of fundraising events.

We continue to collaborate academically with local universities, and our science, technology, engineering and maths (STEM) ambassadors encourage students to select STEM subjects at an early age, with members of our laboratory teams providing local schoolchildren with valuable insight into careers in science.

Know more about our Environmental, Social and Governance (ESG) Strategy.


We are proud to have a culture of making the right decisions and doing the right thing, and it plays an important role in ensuring we can continue to create long-term value for all our stakeholders. Our governance structures support and enable our workforce to give their best and achieve high standards, which, in turn, drive strong business performance.

As a responsible employer operating in a highly regulated industry, we have a comprehensive Code of Conduct and supporting policies, which set standards for ensuring our business activities are conducted responsibly for the benefit of our shareholders, clients, employees and suppliers.

Know more about our Environmental, Social and Governance (ESG) Strategy.